Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction. Leishmaniasis is a parasitic disease caused about twenty differents species of the Leishmania protozoo.Transmitted to humans by the bite of a female midge of the genus Phlebotomine sp. The clinical manifestations are variable and are related to the infected species, their relationship with the environment and the host immune response. Mucocutaneous leishmaniasis (MCL), affect the skin and mucous membranes of the upper respiratory tract, is present in Latin America, produced mainly by Leishmania (Vianna) braziliensis. The initial signs first signs are erythema and ulcerations in the nostrils, followed by destructive inflammation that can spread to involve the nasal septum, in some cases, pharynx or larynx, severely disfiguring the face and compromise the patient’s life. Clinical case. A 90 year old male from the Northwest of Pichincha province, who has several ulcerative lesions in the right nasal bridge, inner corner of the right eye and ipsilateral cheek covering an area of approximately 4 cm in diameter is presented. Multiple doses of pentavalent antimony (Glucantime©) were applied because it was suspected MCL. Diagnostic tests for Leishmaniasis (smear, culture and PCR) were negative. Histopathological examination determined that it was a basal cell skin carcinoma. Results. The skin biopsy sample determined a lesion with basal cell carcinoma, we have referred the patient to SOLCA. Discussion. There are some differential diagnoses of MCL in endemic areas, skin carcinoma being one of which doctors and laboratory technicians should take into account at the time of diagnosis. In addition, MCL diagnoses should be confirmed with laboratory tests to avoid misuse of antimonials. Conclusions. In endemic areas of MCL, a proper differential diagnosis must be performed for ulcerative lesions such as basal cell carcinoma of the skin, avoiding the indiscriminately administration of pentavalent antimony.
Calvopina M, Armijos RX, Marco JD, Uezato H, Kato H, Gomez EA, Korena- ga M, Barroso PA, Mimori T, Cooper PJ, Nonaka S, Hashiguchi Y. Leishmania isoenzyme polymorphisms in Ecuador: relationships with geographic distribu- tion and clinical presentation. BMC Infect Dis. 2006 Sep 13;6:139. PubMed PMID0: 16968553; PubMed Central PMCID: PMC1578576.
Zegarra-del-Carpio R, Sánchez-Saldaña L. Leishmaniasis cutánea: Presentación en placa verrucosa. Dermatología Peru. 2005;15(1):62–5. Disponible en: http:// sisbib.unmsm.edu.pe/bvrevistas/dermatologia/v15_n1/PDF/a10.pdf
Organización Mundial de la Salud. Con- trol de la leishmaniasis. Informe de la Secretaría. Ser Inf técnicos [Internet]. 2010;949. EB126/16. Disponible en: http://apps.who.int/gb/ebwha/pdf_files/ EB126/B126_16-sp.pdf
Hashiguchi Y, Hosokawa A, Maruno M, Takamiyagi A, Nonaka S, Gomez E, et al. Differential diagnosis of cutaneous leish- maniasis in endemic areas of Ecuador. In: Studies on New World leishmaniasis and its transmission with particular refer- ence to Ecuador. Kochi, Japan. Research report series; 2001. p. 58–68. Disponible en:https://ir.kochi-u.ac.jp/dspace/bit- stream/10126/4170/1/leishmaniasis5.pdf
McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJM. 2014 Jan;107(1):7-14. DOI: 10.1093/ qjmed/hct116. Epub 2013 Jun 5. Review. PubMed PMID: 23744570; PubMed Cen- tral PMCID: PMC3869292. [Internet]. Disponible en: http://www.qjmed.ox- fordjournals.org/cgi/doi/10.1093/qjmed/ hct116.
Vázquez-Cajina A. Dermatología. Revis- ta Médica de Costa Rica y Centroamérica LXIX (603) 325-329, 2012. Disponible en: http://www.binasss.sa.cr/revistas/ rmcc/603/art2.pdf
Rueda X, Hart AA De, Aristizabal L. Guías de práctica clínica para el trata- miento del carcinoma basocelular. Rev Asoc Col Dermatol. 2008;16(2):102–17. Disponible en: https://www.scribd.com/document/238370399/Articulo-de-Re- vision-Guias-de-Practica-Clinica-Pa- ra-El-Tratamiento-Del-Carcinoma-Bas- ocelular
TenSeldam R, Helwig E. Histologi- cal typing of kidney tumours. Inter- national classification of tumours. In: International Histological Classifica- tion of Tumours. World Health Orga- nization; 1974. p. 78–9. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/41600/9241760257_eng.pd- f?sequence=1&isAllowed=y
Miranda-Villasana JE, Quintana-Guadar- rama S, Piña-Cortés VA, López-Delgadil- lo S, Márquez-Flores RJ. Carcinoma bas- ocelular: presentación de un caso clínico. Revista ADM 2014; 71 (5): 231-236. Dis- ponible en: http://www.medigraphic.com/ pdfs/adm/od-2014/od145f.pdf
Briceño R W, Pérez H. Cáncer de piel: Caso columella nasal. Derma- tología Venezolana. Vol. 45, Nº 4, 2007. 2007;45(4):33–6. Disponible en: http:// revista.svderma.org/index.php/ojs/article/ viewFile/98/98
Carucci, J. & Leffell, D. (2008). Basal cell carcinoma. In: Fitzpatrick’s Derma- tology in General Medicine. Wolf, K. Goldsmith, L.; Gilchrest, B.; Paller, A. & Leffell, D. pp. 1036-1042, McGraw Hill, ISBN 0-07-146690-8, New York. Disponible en: https://accessmedicine. mhmedical.com/content.aspx?section- id=41138832&bookid=392.
González VM, Gramajo MJ, Escobar CM, Costas LR, Ruzzi IM, Picardi NL, et al. Dermatoscopía del carcinoma bas- ocelular: criterios clásicos y actuales. Arch Argent Dermatol. 2012;62:87–91. Disponible en: http://www.archivosder- mato.org.ar/uploads/087 %20derma- toscop %C3 %ADa %20carcinoma %20 basocelular.pdf
Montenegro-Idrogo, Juan J, Mon- tañez-Valverde, Raúl A, Chian, Cesar, & Benites-Villafane, Carlos. (2014). Leish- maniasis mucocutánea en un paciente con infección por VIH: Case report. Re- vista chilena de infectología, 31(5), 610-614. https://dx.doi.org/10.4067/S0716-10182014000500015
Machado-Alba, Jorge E., García-Betan- court, Santiago, & Medina-Morales, Di- ego Alejandro. (2016).Leishmaniasis mucosa en un lactante. Una presentación inusual de una enfermedad olvidada. In- fectio, 20(3), 165-168. https://dx.doi. org/10.1016/j.infect.2015.06.004
Maita Garcia, Ximena, Miranda Guti- érrez, Claudia, Marañon Mendoza, Liz- et Carolina, Carvajal Yañez, Noelia, & Santander López, Ana. (2011). Epidemio- logical characteristics of Leishmaniasis in Cochabamba department during the peri- od 2002-2010. Revista Científica Ciencia Médica, 14(2), 8-11. Recuperado en 25 de septiembre de 2018, de http://www.scie- lo.org.bo/scielo.php?script=sci_arttex- t&pid=S1817-74332011000200003&l- ng=es&tlng=en.
Thakur L, Singh KK, Shanker V, Negi A, Jain A, Matlashewski G, et al. (2018) Atypical leishmaniasis: A global per- spective with emphasis on the Indian subcontinent. PLoS Negl Trop Dis 12(9): e0006659. https://doi.org/10.1371/jour- nal.pntd.0006659
Ruiz Lascano, Alejandro, Kuznitzky, Raquel, Garay, Iliana, Ducasse, Cristina, & Albertini, Ricardo. (2005). Factores de riesgo para carcinoma bas- ocelular: Estudio de casos controles en Córdoba. Medicina (Buenos Aires), 65(6), 495-500. Recuperado en 01 de octubre de 2018, de http://www.scielo.org.ar/scielo.php?script=sci_arttex- t&pid=S0025-76802005000600004&l- ng=es&tlng=pt.
Nova-Villanueva, John, Sánchez-Vane- gas, Guillermo, & Porras de Quintana, Luisa. (2007). Cáncer de Piel: Perfil Ep- idemiológico de un Centro de Referen- cia en Colombia 2003-2005. Revista de Salud Pública, 9(4), 595-601. Retrieved October 01, 2018, from http://www.sci- elo.org.co/scielo.php?script=sci_arttex-t&pid=S0124-00642007000400012&l- ng=en&tlng=pt
Rojas Cabrera, Ernesto, Guzmán Rive- ro, Jose Miguel, & Verduguez Orellana, Aleida. (2011). Leishmaniasis laryngeal mucous without apparent input: a clin- ical case presentation. Gaceta Médica Boliviana, 34(2), 91-93. Recuperado en 01 de octubre de 2018, de http://www.sci- elo.org.bo/scielo.php?script=sci_arttex-t&pid=S1012-29662011000200008&l- ng=es&tlng=en.
Machado-Alba, Jorge E., García-Betan- court, Santiago, & Medina-Morales, Di- ego Alejandro. (2016). Leishmaniasis mucosa en un lactante. Una presentación inusual de una enfermedad olvidada. In- fectio, 20(3), 165-168. https://dx.doi. org/10.1016/j.infect.2015.06.004
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.